EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

An assessment of the BEST-CLI Trial demonstrates that infrainguinal bypass offers a potential advantage in smokers with chronic limb-threatening ischemia

Andrew R Barleben, Rohini J Patel, Alik Farber, Matthew T Menard, Maarit Venermo, Mark A Creager, Katherine M Reitz, Michael Strong, Kenneth Rosenfield, Gheorghe Doros, Michael Dake, Rabih A Chaer

Journal of Vascular Surgery · 2025

DOI: 10.1016/j.jvs.2025.02.015 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Andrew R Barleben und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, University of California, San Diego, CA. Electronic address: abarleben@health.ucsd.edu. Hauptthemen laut MEDLINE: Ischemia, Peripheral Arterial Disease, Smoking, Endovascular Procedures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IschemiaPeripheral Arterial DiseaseSmokingEndovascular ProceduresSmokersChronic Limb-Threatening IschemiaSaphenous VeinVascular GraftingLower ExtremityHumansMaleFemaleAgedRisk FactorsTreatment OutcomeAmputation, SurgicalTime FactorsMiddle AgedProspective StudiesLimb SalvageRisk AssessmentChronic DiseaseCritical IllnessPostoperative ComplicationsAged, 80 and over

Stichwörter der Autor:innen

BEST-CLIBypassCLTIEndovascularPeripheral interventionsSmoking

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, University of California, San Diego, CA. Electronic address: abarleben@health.ucsd.edu.
  • Division of Vascular and Endovascular Surgery, University of California, San Diego, CA.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA.
  • Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Department of Vascular Surgery, HUCH Abdominal Centre, Helsinki, Finland.
  • Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH.

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • Novo Nordisk Fonden
  • National Institutes of Health

Zitieren

APA

Barleben, A. R., Patel, R. J., Farber, A., Menard, M. T., Venermo, M., Creager, M. A., Reitz, K. M., Strong, M., Rosenfield, K., Doros, G., Dake, M., & Chaer, R. A. (2025). An assessment of the BEST-CLI Trial demonstrates that infrainguinal bypass offers a potential advantage in smokers with chronic limb-threatening ischemia. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.02.015

Vancouver

Barleben AR, Patel RJ, Farber A, Menard MT, Venermo M, Creager MA, et al. An assessment of the BEST-CLI Trial demonstrates that infrainguinal bypass offers a potential advantage in smokers with chronic limb-threatening ischemia. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.02.015

BibTeX
@article{Barleben2025,
  author = {Barleben, Andrew R and Patel, Rohini J and Farber, Alik and Menard, Matthew T and Venermo, Maarit and Creager, Mark A and Reitz, Katherine M and Strong, Michael and Rosenfield, Kenneth and Doros, Gheorghe and Dake, Michael and Chaer, Rabih A},
  title = {An assessment of the BEST-CLI Trial demonstrates that infrainguinal bypass offers a potential advantage in smokers with chronic limb-threatening ischemia},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  doi = {10.1016/j.jvs.2025.02.015}
}
Kostenlos starten →